Baseline quality of life measured with the EORTC QLQ-C30 helps to select a subset of ‘good prognosis’ metastatic hormone refractory prostate cancer patients

✍ Scribed by L. Collette; S.D. Fossa; G.O.N. Oosterhof; W. Albrecht; G. van Andel; T.M. de Reijke; A. Bottomley

• Book ID: 117658653
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 165 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(01)81290-9